1-Bromo-4-Propylbenzene - Manufacturers, Suppliers, Factory from China

1-Bromo-4-Propylbenzene, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

1-Bromo-4-Propylbenzene CAS 588-93-2 Purity 99.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 1-Bromo-4-Propylbenzene CAS 588-93-2 Purity >99.0% (GC)
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.09.22 00:46:08
2022.08.04 09:49:33
2022.07.01 23:54:17
2021.11.22 04:23:57
2021.11.19 00:05:51
2021.11.17 16:07:56

1-Bromo-4-Propylbenzene - Manufacturers, Suppliers, Factory from China

Related Products

1-Bromo-4-Propylbenzene CAS 588-93-2 Purity >99.0% (GC)

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

6-Iodoindazole CAS 261953-36-0 Purity >98.5% (HPLC) Factory

Titanium(IV) Isopropoxide CAS 546-68-9 Ti 16.6~16.9% Factory High Quality

(S)-(-)-Tetrahydro-2-furoic Acid CAS 87392-07-2 Assay ≥98.0% Optical Purity ≥99.0% (GC) High Purity

Fmoc-Trp-OH CAS 35737-15-6 Fmoc-L-Tryptophan Purity >99.0% (HPLC) Factory

Boc-Arg(Z)2-OH CAS 51219-19-3 Purity >98.0% (HPLC)

2-Bromo-4-Fluorotoluene CAS 1422-53-3 Purity >99.0% (GC) Factory

Pyrimidine CAS 289-95-2 Assay ≥99.5% (GC) Factory Hot Sale

N-(4-Aminobenzoyl)-L-Glutamic Acid H-4-ABZ-Glu-OH CAS 4271-30-1 Purity ≥99.0% (HPLC) Folic Acid Intermediate Factory

4-Bromo-D-Phenylalanine CAS 62561-74-4 H-D-Phe(4-Br)-OH Assay >99.0%

Ganciclovir CAS 82410-32-0 API BW 759 GCV Antiviral CMV Inhibitor High Quality

4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS 327-78-6 Purity ≥99.0% Sorafenib Tosylate Intermediate Factory

Fmoc-Arg-OH CAS 91000-69-0 Nα-Fmoc-L-Arginine Purity >99.0% (HPLC)

Xi presents award to top scientists

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

New COVID treatments offer hope

Paxlovid: what we know about Pfizer's Covid-19 pill

2022.09.22 00:46:08

2022.08.04 09:49:33

2022.07.01 23:54:17

2021.11.22 04:23:57

2021.11.19 00:05:51

2021.11.17 16:07:56

related search